drugset / Trial / NCT03126097
A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the effect of single and multiple doses of JNJ-64155806 on the steady-state pharmacokinetics (PK) of ethinylestradiol and drospirenone and vice versa in healthy female participants.
Timeline
- Start
- 2017-04-13
- Primary completion
- 2017-05-26
- Completion
- 2017-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-64155806 | Unknown | 150 mg | — |
| Subject | drospirenone | Unknown | 3 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 0.02 mg | Oral |
Indications
No indication recorded.